Insider trade

Biodesix (BDSX): Chief Commercial Officer sold ~$16K

Kieran O'kane, Chief Commercial Officer at Biodesix, sold ~$16K of Biodesix shares.

~$16K
Approx. value · 18K sh @ $0.9242: 128K
Holds after · shares reported

Traded: Feb 11, 2025
Filed: Feb 12, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Feb 11, 2025 · this disclosureInsiderOfficer sold ~$16K of BDSX shares in the open market

What came next

Feb 11, 2025Insider · 4 peopleInsiders: 4 sales (~$119K)
May 12, 2025Insider · 5 peopleInsiders: 5 sales (~$1K)
May 13, 2025Insider · 5 peopleInsiders: 5 sales (~$1K)
May 16, 2025InsiderDirector purchased ~$1.07M of BDSX shares in the open market
May 19, 2025InsiderDirector purchased ~$247K of BDSX shares in the open market

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Biodesix

For Biodesix, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BDSX page.

Other recent filings by Kieran O'kane, Chief Commercial Officer

The full history of Kieran O'kane, Chief Commercial Officer is on the profile page.

How this filing works

Explore the data

Other disclosures at Biodesix

Everything OQRO holds on this company is on its BDSX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data